Drug Safety
Drug Safety
Ensuring Patient Well-being Through Pharmacovigilance
At Oceanic Pharma, Drug Safety—also known as Pharmacovigilance—is a fundamental component of our commitment to patient well-being. Pharmacovigilance encompasses the scientific processes and activities related to the detection, evaluation, understanding, and prevention of adverse effects or any other medicine-related issues. Our objective is to ensure that the benefits of our medicinal products consistently outweigh any potential risks.
Our Commitment to Patient Safety
Oceanic Pharma is dedicated to upholding the highest standards of patient safety across the entire product lifecycle, from research and development to post-marketing surveillance.
- Prioritizing patient safety in all operational decisions
- Maintaining robust pharmacovigilance systems
- Ensuring timely and transparent safety communication
Safety Monitoring Activities
Adverse Event Monitoring
Continuous collection, analysis, and medical assessment of adverse events and adverse drug reactions.
Risk Management
Identification and mitigation of potential safety risks through structured risk management plans.
Post-Marketing Surveillance
Ongoing evaluation of product safety following market authorization.
Regulatory Reporting
Accurate and timely submission of safety reports to relevant health authorities.
What We Monitor
- Adverse Drug Reactions (ADRs) – Unintended harmful responses associated with medicines.
- Adverse Events (AEs) – Any unfavorable medical occurrence during treatment.
- Special Safety Situations – Medication errors, overdose, misuse, pregnancy exposure and quality complaints.
Reporting Adverse Events
Healthcare professionals, patients, distributors, and partners are encouraged to report any suspected adverse events or safety concerns related to our products.
Drug Safety Contact UsWhy Drug Safety Matters
While clinical trials provide essential safety data, they are conducted under controlled conditions with limited patient populations. Continuous pharmacovigilance allows Oceanic Pharma to monitor real-world use and maintain an up-to-date benefit–risk profile for each product.
Conclusion
Oceanic Pharma remains firmly committed to protecting public health through strong pharmacovigilance practices, regulatory compliance, and ethical responsibility. By continuously monitoring the safety of our products and engaging transparently with stakeholders, we strive to deliver safe, effective, and high-quality medicines worldwide.